Abstract:Abstract Background The central nervous system (CNS) is an immunologically privileged site to which access for circulating immune cells is tightly controlled by the endothelial blood–brain barrier (BBB) located in CNS microvessels. Under physiological conditions immune cell migration across the BBB is low. However, in neuroinflammatory diseases such as multiple sclerosis, many immune cells can cross the BBB and cause neurological symptoms. Extravasation of circulating immune cells is a multi-step process that is regulated by the sequential interaction of different adhesion and signaling molecules on the immune cells and on the endothelium. The specialized barrier characteristics of the BBB, therefore, imply the existence of unique mechanisms for immune cell migration across the BBB. Methods and design An in vitro mouse BBB model maintaining physiological barrier characteristics in a flow chamber and combined with high magnification live cell imaging, has been established. This model enables the molecular mechanisms involved in the multi-step extravasation of T cells across the in vitro BBB, to be defined with high-throughput analyses. Subsequently these mechanisms have been verified in vivo using a limited number of experimental animals and a spinal cord window surgical technique. The window enables live observation of the dynamic interaction between T cells and spinal cord microvessels under physiological and pathological conditions using real time epifluorescence intravital imaging. These in vitro and in vivo live cell imaging methods have shown that the BBB endothelium possesses unique and specialized mechanisms involved in the multi-step T cell migration across this endothelial barrier under physiological flow. The initial T cell interaction with the endothelium is either mediated by T cell capture or by T cell rolling. Arrest follows, and then T cells polarize and especially CD4 + T cells crawl over long distances against the direction of flow to find the rare sites permissive for diapedesis through the endothelium. Discussion The sequential use of in vitro and in vivo live cell imaging of T cells interacting with the BBB allows us to delineate the kinetics and molecular determinants involved in multistep extravasation of encephalitogenic T cells across the BBB.

Mechanisms of Dendritic Cell Trafficking Across the Blood–brain Barrier

Transmigration across a Steady-State Blood-Brain Barrie Induces Activation of Circulating Dendritic Cells Partly Mediated by Actin Cytoskeletal Reorganization

Dendritic Cell-Targeted Therapies to Treat Neurological Disorders

Dendritic cell CNS recruitment correlates with disease severity in EAE via CCL2 chemotaxis at the blood–brain barrier through paracellular transmigration and ERK activation

Lectin-targeted dendritic cell immunotherapies against experimental autoimmune encephalitis/multiple sclerosis (CAM5P.242)

Immune cells as messengers from the CNS to the periphery: the role of the meningeal lymphatic system in immune cell migration from the CNS

Dendritic cell migration in inflammation and immunity

CNS and CNS Diseases in Relation to Their Immune System

Migration of Dendritic Cells: Physical Principles, Molecular Mechanisms, and Functional Implications

Immune cells: potential carriers or agents for drug delivery to the central nervous system

Brain endothelial tricellular junctions as novel sites for T cell diapedesis across the blood–brain barrier

Live cell imaging techniques to study T cell trafficking across the blood-brain barrier in vitro and in vivo

Regulation of autoimmune‐mediated neuroinflammation by endothelial cells

Mechanisms of myeloid cell entry to the healthy and diseased central nervous system

Meningeal Immunity and Neurological Diseases: New Approaches, New Insights

Emergence of the brain-border immune niches and their contribution to the development of neurodegenerative diseases

The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases

Frontiers of Neurodegenerative Disease Treatment: Targeting Immune Cells in Brain Border Regions

Sniping the scout: Targeting the key molecules in dendritic cell functions for treatment of autoimmune diseases

Macrophages as Nanocarriers for Drug Delivery: Novel Therapeutics for Central Nervous System Diseases.

Meningeal lymphatics and their role in CNS disorder treatment: moving past misconceptions